<DOC>
	<DOCNO>NCT01364194</DOCNO>
	<brief_summary>The purpose study evaluate efficacy periarticular injection 0.25 % bupivacaine control pain total knee replacement improve quality post-operative care .</brief_summary>
	<brief_title>Local Infiltration With Bupivacaine Increase Quality Post-operative Pain Control Total Knee Replacement</brief_title>
	<detailed_description>Compare post operative pain control total knee replacement periarticular injection 0.25 % bupivacaine compare 0.9 % normal saline .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Joint Diseases</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>primary osteoarthritis patient undergoing total knee replacement Siriraj Hospital BMI 2035 full understand question trial allergy NSAIDs , Acetaminophen , Bupivacaine blood creatinine 1.5 mg/dl creatinine clearance le 60 mL/min abnormal liver function previous surgery knee undergo total knee replacement patient could receive spinal anesthesia</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Post operative pain</keyword>
	<keyword>Total knee replacement</keyword>
	<keyword>Total knee arthroplasty</keyword>
	<keyword>Bupivacaine</keyword>
	<keyword>Periarticular injection</keyword>
	<keyword>Placebo</keyword>
	<keyword>Morphine consumption</keyword>
</DOC>